M. Smith

发表

Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.

C. Chidester, C. Lin, R. Lahti, 1993, Journal of medicinal chemistry.

Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage.

A. Richards, M. Nicholls, M. Smith, 1998, Clinical chemistry.

The chemical structure of U99194A.

A. Carlsson, K. Svensson, S. Haadsma-Svensson, 1995, Journal of neural transmission. General section.

Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.

A. Richards, E. Espiner, M. Smith, 2000, The Journal of endocrinology.

Assayof Endopeptidase-24. 11 Activityin PlasmaAppliedto In VivoStudiesof Endopeptidase Inhibitors

E. Espiner, J. Livesey, M. Smith, 1992 .

Assay of endopeptidase-24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors.

E. Espiner, J. Livesey, M. Smith, 1992, Clinical chemistry.

Degradation of Human Adrenomedullin(1-52) by Plasma Membrane Enzymes and Identification of Metabolites

M. Nicholls, S. Brennan, M. Smith, 1997, Peptides.

Functional Roles for Dopamine-Receptor Subtypes

M. Piercey, M. Smith, M. Camacho-Ochoa, 1995 .

Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.

R. Mccall, K. Svensson, M. Smith, 1998, Journal of medicinal chemistry.

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.

M. Piercey, R. Mccall, M. Bienkowski, 1994, The Journal of pharmacology and experimental therapeutics.

Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.

M. Piercey, W. E. Hoffmann, M. Smith, 1996, European journal of pharmacology.

Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.

M. Piercey, J. T. Lum-Ragan, M. Smith, 1994, The Journal of pharmacology and experimental therapeutics.

The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity

A. Carlsson, K. Svensson, S. Haadsma-Svensson, 2005, Journal of Neural Transmission / General Section JNT.

Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites.

M. Piercey, N. F. Nichols, M. Smith, 1997, Journal of medicinal chemistry.

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

R. Lahti, M. Smith, S A Rees, 1996, Journal of medicinal chemistry.

Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.

K. Svensson, C. Lin, S. Haadsma-Svensson, 1995, Journal of medicinal chemistry.

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

M. Piercey, R. Mccall, K. Merchant, 1996, The Journal of pharmacology and experimental therapeutics.

Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

A. Carlsson, L. Hansson, K. Svensson, 1994, Journal of medicinal chemistry.

Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans.

A. Carlsson, N. F. Nichols, K. Svensson, 2001, Journal of medicinal chemistry.

U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes.

M. Smith, D. Carter, W. Im, 1995, The Journal of pharmacology and experimental therapeutics.

Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.

M. Smith, T. Poel, D. Dinh, 1997, European journal of pharmacology.

Functional Expression of GABAA Chloride Channels and Benzodiazepine Binding Sites in Baculovirus Infected Insect Cells

P. Seeburg, W. Gale, M. Smith, 1992, Bio/Technology.

PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties.

S. Franklin, C. S. Himes, M. Smith, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype.

M. Piercey, M. Smith, V. Sethy, 1996, European journal of pharmacology.

Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.

M. Piercey, R. Mccall, C. Chidester, 1993, Journal of Medicinal Chemistry.

Regioselective Synthesis of 3‐Aryl Substituted Pyrrolidines via Palladium Catalyzed Arylation: Pharmacological Evaluation for Central Dopaminergic and Serotonergic Activity.

A. Carlsson, K. Svensson, M. Smith, 1997 .

Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.

M. Piercey, R. Mccall, M. Smith, 1993, Journal of medicinal chemistry.

Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.

M. Smith, R. Mortimore, S. Schlachter, 1994, Methods and findings in experimental and clinical pharmacology.

Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity.

L. J. King, K. Svensson, M. Smith, 1995, Journal of medicinal chemistry.

Naphtho and benzo analogues of the kappa opioid agonist trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] benzeneacetamide.

R. Lahti, M. Smith, S. Mizsak, 1991, Journal of medicinal chemistry.